Markets:

Overview

News

Currencies

International

Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.4861 -0.0089 (-1.80%)

Streaming Delayed Price Updated: 3:52 PM EDT, Apr 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday ↗

November 01, 2022

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...

Via Benzinga

Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session ↗

October 31, 2022

Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its...

Via Benzinga

Ensysce Biosciences' Newly Formulated Oxycodone Product Shows Resistance To Tampering, Abuse ↗

October 31, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

October 31, 2022

During Monday's session, 96 stocks hit new 52-week lows.

Via Benzinga

Ensysce Biosciences Announces Positive Topline Results of Clinical Study Evaluating Human Abuse Potential of Intranasal Administration of PF614, a TAAP Abuse-Deterrent Oxycodone Extended-Release Product

October 31, 2022

Via ACCESSWIRE

Ensysce Biosciences Announces First Subjects Dosed in Second Human Abuse Potential Study

October 28, 2022

Via ACCESSWIRE

Stocks That Hit 52-Week Lows On Thursday ↗

October 20, 2022

Thursday saw 177 companies set new 52-week lows.

Via Benzinga

Ensysce Biosciences Announces Initiation of Second Human Abuse Potential Study, Being Conducted by DVCR

September 22, 2022

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

October 28, 2022

Pre-market stock movers continue to be a major topic as we dive into the latest news investors need to know about on Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 27, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 26, 2022

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $11.8 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 26, 2022

It's time to start off the day with a breakdown of the biggest pre-market stock movers for Wednesday morning and the latest news!

Via InvestorPlace

Why Skechers Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket ↗

October 26, 2022

Gainers Ensysce Biosciences, Inc. (NASDAQ: ENSC) rose 53.5% to $0.32 in pre-market trading after gaining 13% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 25, 2022

Gainers DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million.

Via Benzinga

Why Olaplex Holdings Shares Are Trading Lower By 42%; Here Are 27 Stocks Moving Premarket ↗

October 19, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares rose 65.8% to $0.3847 in pre-market trading after declining over 3% on Tuesday.

Via Benzinga

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗

September 28, 2022

Gainers

Via Benzinga

This Innovative Biotech Firm Is Changing The Way We See Medication ↗

September 26, 2022

Sign up for this week’s All Access giveaway here! Dr. Lynn Kirkpatrick, CEO of Ensysce Biosciences (NASDAQ: ENSC), was a guest on Benzinga’s All Access on Sep 23, 2022.

Via Benzinga

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket ↗

September 22, 2022

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 21, 2022

Gainers Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million.

Via Benzinga

Ensysce Biosciences to Present at Benzinga All Access Event on Friday, September 23, 2022

September 21, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 15, 2022

Via Benzinga

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket ↗

September 15, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 14, 2022

Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 14, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 14, 2022

We're starting off Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares!

Via InvestorPlace

Why Kaspien Holdings Is Trading Lower By 13%; Here Are 21 Stocks Moving Premarket ↗

September 14, 2022

Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 54.3% to $28.56 in pre-market trading following effect of 1:50 reverse stock split.

Via Benzinga

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗

September 14, 2022

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...

Via Benzinga

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

Ensysce Biosciences Announces Results of Special Meeting of Stockholders

September 08, 2022

Via ACCESSWIRE

Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

September 08, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.